價(jià)格 | ¥965.1 | ¥4382.48 |
包裝 | 5 MG | 25 MG |
最小起訂量 | 1MG |
發(fā)貨地 | 上海 |
更新日期 | 2023-10-27 |
中文名稱:JP4-039 | CAS:1205492-16-5 |
品牌: Sigma | 純度規(guī)格: ≥98% (HPLC) |
產(chǎn)品編號(hào) | SML2807 |
品牌 | Sigma |
形式 | powder |
顏色 | faint yellow to dark orange |
測(cè)定 | ≥98% (HPLC) |
分子量 | 424.60 |
溶解性 | DMSO: 2?mg/mL, clear |
質(zhì)量水平 | 100 |
儲(chǔ)存溫度 | ?20°C |
別名
4-[[(3E,5S)-5-[[(1,1-Dimethylethoxy)carbonyl]amino]-7-methyl-1-oxo-3-octen-1-yl]amino]-2,2,6,6-tetramethyl-1-piperidinyloxy,JP 4-039
生化/生理作用
JP4-039 is an electron-/reactive oxygen species (ROS)-scavenging GS-nitroxide composed of 4-amino-TEMPO and a truncated gramicidin S (GS) mitochrondria-targeting sequence. JP4-039 is a superior irradiation mitigator than XJB-5-131 (33% vs. 20% mice survial rate on day 35 with respective compound; 23.6 μmol/kg iv. 24 hr post 9.5 Gy whole body irradiation), while displaying weaker anti-ferroptotic potency (EC50 = 3.58 μM/1.27 μM against 10 μM erastin-/2 μM RSL3-induced HT-1080 ferroptosis vs. 114 nM/68 nM with XJB-5-131) due to lower lipophilicity & mitochondria enrichment. Typical dosing range: 40 nM-10 μM in cultures and 10-20 mg/kg in mice (im., ip., iv.) in vivo.
成立日期 | 2005-12-27 (20年) | 注冊(cè)資本 | 600.0萬(wàn)美元 |
員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1億以上 |
主營(yíng)行業(yè) | 分析化學(xué),材料化學(xué),生物化工,化學(xué)試劑,催化劑 | 經(jīng)營(yíng)模式 | 貿(mào)易,試劑,定制,服務(wù) |